Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-11 EMPFIELD JAMES R. EVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +65,000 65,000
2023-03-10 EMPFIELD JAMES R. EVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion +20,000 $3.10 $62K 30,000
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion +45,000 $4.75 $214K 75,000
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Shares withheld for taxes −7,257 $38.02 $276K 67,743
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Sale −35,868 $38.08 $1.4M 31,875
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Sale −21,875 $38.68 $846K 10,000
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion · Stock Option (Right to Buy) −20,000 0
2022-08-12 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion · Stock Option (Right to Buy) −45,000 0
2022-03-10 EMPFIELD JAMES R. EVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +65,000 65,000
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion +2,500 $8.40 $21K 12,500
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Shares withheld for taxes −695 $30.23 $21K 11,805
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion +40,000 $6.76 $270K 51,805
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Shares withheld for taxes −8,952 $30.23 $271K 42,853
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Sale −1,805 $30.62 $55K 41,048
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Sale −31,048 $30.54 $948K 10,000
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion · Stock Option (Right to Buy) −2,500 0
2022-03-07 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion · Stock Option (Right to Buy) −40,000 0
2022-03-04 EMPFIELD JAMES R. EVP, Drug Discovery Exercise or conversion +25,000 $8.40 $210K 35,000
2022-03-04 EMPFIELD JAMES R. EVP, Drug Discovery Shares withheld for taxes −6,685 $31.42 $210K 28,315

Page 1 of 2 · 25 trades